ICON Public Limited (ICLR) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ICON Public Limited (ICLR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

200.34

-17.65 (-8.10%)

At close: Jan 14, 2025, 3:59 PM

199.94

-0.20%

After-hours Jan 14, 2025, 07:59 PM EST

undefined% (undefined)

Bid	195
Market Cap	16.54B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	8.98
PE Ratio (ttm)	22.31
Forward PE	n/a
Analyst	Buy

Ask	199.95
Volume	1,684,950
Avg. Volume (20D)	1,348,534
Open	199.07
Previous Close	217.99
Day's Range	197.91 - 209.74
52-Week Range	183.38 - 347.72
Beta	undefined

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, incl...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date May 15, 1998

Employees 42,250

Stock Exchange NASDAQ

Ticker Symbol ICLR

Website https://www.iconplc.com

Analyst Forecast

According to 12 analyst ratings, the average rating for ICLR stock is "Buy." The 12-month stock price forecast is $280, which is an increase of 39.76% from the latest price.

Buy 91.67%

Hold 8.33%

Sell 0.00%

Stock Forecasts

Next Earnings Release

ICON Public Limited is scheduled to release its earnings on Feb 19, 2025, during market hours.
Analysts project revenue of $2.03B, reflecting a -1.75% YoY shrinking and earnings per share of 3.4, making a -1.73% decrease YoY.

Why Price Moved

15 hours ago · Source New

-8.14%

ICON shares are trading lower after the company is... Unlock content with Pro Subscription

1 week ago · Source

+3.28%

Icon shares are trading higher after RBC Capital initiated coverage on the stock with an Outperform rating and announced a price target of $263.

News

1 week ago · businesswire.com

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer's and Related Disorders – ICON Survey

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pha...

1 week ago · businesswire.com

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference.

3 weeks ago · businesswire.com

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME...

3 weeks ago · zacks.com

New Strong Sell Stocks for December 20th

ICLR, BHP and CR have been added to the Zacks Rank #5 (Strong Sell) List on December 20, 2024.

4 weeks ago · businesswire.com

ICON Announces Appointment of Chief Operating Officer

DUBLIN--(BUSINESS WIRE)--ICON Announces Appointment of Chief Operating Officer.

1 month ago · seekingalpha.com

ICON: A High Probability Of Success In The Uncertain R&D Process

Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain st...

1 month ago · zacks.com

New Strong Sell Stocks for December 10th

BALY, ENPH and ICLR have been added to the Zacks Rank #5 (Strong Sell) List on December 10, 2024.

1 month ago · businesswire.com

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “...

1 month ago · businesswire.com

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Co...

1 month ago · businesswire.com

The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the...

2 months ago · businesswire.com

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICON Public Limit...

2 months ago · businesswire.com

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Com...

2 months ago · businesswire.com

The Law Offices of Frank R. Cruz Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the ...

2 months ago · zacks.com

ICLR Misses on Q3 Earnings, Lowers 2024 Guidance, Stock Falls

ICON's third-quarter 2024 earnings lag estimates due to its large customers undergoing significant development model shifts with resulting cost pressures and the biotech market's slower recovery.

2 months ago · seekingalpha.com

ICON Public Limited Company (ICLR) Q3 2024 Earnings Call Transcript

ICON Public Limited Company (NASDAQ:ICLR ) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET Company Participants Kate Haven - Vice President of Investor Relations Steve Cutler - Chief Exec...

2 months ago · zacks.com

Icon PLC (ICLR) Lags Q3 Earnings and Revenue Estimates

Icon PLC (ICLR) came out with quarterly earnings of $3.35 per share, missing the Zacks Consensus Estimate of $3.85 per share. This compares to earnings of $3.30 per share a year ago.

3 months ago · zacks.com

Icon PLC (ICLR) Earnings Expected to Grow: Should You Buy?

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.